Tumor necrosis factor alpha neutralization attenuates immune checkpoint inhibitor-induced activation of intermediate monocytes in synovial fluid mononuclear cells from patients with inflammatory arthritis

OBJECTIVE: During treatment with immune checkpoint inhibitors (ICI) such as the anti-PD-1 antibody pembrolizumab, half of patients with pre-existing inflammatory arthritis experience disease flares. The underlying immunological mechanisms have not been characterized. Here, we investigate the effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Sørensen, Anne Sofie, Andersen, Morten Nørgaard, Juul-Madsen, Kristian, Broksø, Amalie Dyrelund, Skejø, Cæcilie, Schmidt, Henrik, Vorup-Jensen, Thomas, Kragstrup, Tue Wenzel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842914/
https://www.ncbi.nlm.nih.gov/pubmed/35164829
http://dx.doi.org/10.1186/s13075-022-02737-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842914/
https://www.ncbi.nlm.nih.gov/pubmed/35164829
http://dx.doi.org/10.1186/s13075-022-02737-6

Ejemplares similares